We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Top Brokers
Recent discussions among investors of Oxford Biomedica Plc (OXB) highlight a mix of cautious optimism and frustration, influenced by broader market conditions and specific company developments. Notably, sentiment seems subdued as investors express concern about the company's upcoming results in early April, with many reflecting on their trading strategies amidst fluctuating share prices. Some investors like "steeplejack" have sold a significant portion of their holdings due to market nervousness, while "brucie5" has noted a historical support level around £3, which investors hope will hold. "harry s truman" remarked that significant changes in stock value could emerge depending on announcements from the company, exemplifying the uncertainty that looms over OXB.
Financial highlights shared in the discussions include a recognition of a one-time expense of $5.4 million linked to a partnership with Bristol Myers Squibb (BMS), which is set to affect the company's financial guidance. This expense, along with ongoing developments in their gene therapy products and the strategic importance of becoming a preferred manufacturer for BMS, underscores potential long-term growth prospects despite immediate pressures. Investor comments reflect a desire for clearer communication from OXB regarding their operations, as observed by comments related to the company's communication practices. Amid this uncertainty, one investor astutely noted, "Resilience is required to solve the puzzle," indicating the sentiment that patience may be crucial while navigating potential short-term volatility.
Overall, while investors remain hopeful about OXB's strategic advancements, their discussions reveal that the community is grappling with a lack of timely communication and clarity on future developments, contributing to a cautious approach in trading the stock.
Show more
Oxford Biomedica PLC (LSE: OXB) announced the total voting rights associated with its ordinary shares as of February 28, 2025. The company reported that its issued share capital consists of 105,975,816 ordinary shares, all of which hold a nominal value of 50 pence each. Notably, there are no shares held in treasury, providing clarity to shareholders regarding their voting rights. This total can be utilized by investors to ascertain their interest in OXB under the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules.
In the broader context of its operations, OXB continues to position itself as a leader in cell and gene therapy manufacturing services. The company focuses on quality and innovation as key drivers in its sector, which is increasingly vital due to the growing demand for advanced therapeutic modalities. Such announcements reflect Oxford Biomedica's commitment to transparency and engagement with its shareholder base while reinforcing its robust standing in the biotechnology industry.
Show more
sj, |
This is just a bit of oversimplified misinformation that is popular on twitter and actually stands up to very little scrutiny. |
Yes GJ , it's amazing that anyone with 34 felony convictions and a rape conviction, who incited an insurrection, sold "Top-Secret" files to foreign nations, and an inveterate lying thief could EVER be considered a candidate for POTUS. I guess we live and learn...🤔 |
The office of President of the USA should be greater than the President who holds it. Many poor presidents have at least held the office well. Others have demeaned the office they serve. |
Harry,Yes, I did watch the videos of the riots, and they very much confirmed all that I had read and seen before.Some people acted in what appeared to be almost bemused good nature, but others were out for blood. However, five people died, so it was serious, but Trump thought not. That sums him up. I'm a full blooded right of center libertarian, but could never support a man like that, even in the face of a Harris shaped alternative.And yes, you are right about the risks of Greece: like many previously communist led countries, it has history of expropriation! My (half hearted) musings have everything in excess of living expenses simply moved straight away from the SIPP into Overseas Bonds, domiciled in Guernsey, which would remove that risk. (Anyone else here got experience of those vehicles? SIPPs and ISA's have pushed them off the radar, but with labour in power I think that may change).And yes too to your observations regarding European migration: almost (?!) as much a mess as in the UK. At the moment, Greece (Crete) is home to a huge number of (illegal) migrants from Albania, Morocco, and Georgia. Everyone else moves on, hoping to get to Germany, Sweden or the UK, which are seen as the easy touches. |
red, |
Good to have so many supporters of Mr Trump here. He is a hero. He will round up all the immigrants and liquidate every last one of them. |
Steeplejack, glad to here you think Trump is a marginally preferable proposition. |
... and her husband is a senior Civil Servant. |
"I believe he's the least worst option for America"Interesting stuff Harry.When you have a Kennedy endorsing Trump,the Democrat camp remains,at heart,disorientated. |
Impressive alternative narrative Harry. |
Which serious journal are you writing for Mr President, sir? I would take a subscription to that in double time. Many thanks. |
Winston Churchill-Many forms of Government have been tried, and will be tried in this world of sin and woe. No one pretends that democracy is perfect or all-wise. Indeed it has been said that democracy is the worst form of Government except for all those other forms that have been tried from time to time....The calibre of the two presidential candidates is deeply disappointing.Thats the dilemma. |
#9066 I certainly couldn't support a government that weaponises the judicial system as the Democrats have done. |
None stranger than folk. |
Harry is composing his one word reply. |
Well said H. |
Type | Ordinary Share |
Share ISIN | GB00BDFBVT43 |
Sector | Medicinal Chems,botanicl Pds |
Bid Price | 301.00 |
Offer Price | 302.00 |
Open | |
Shares Traded | 0.00 |
Last Trade | 00:00:00 |
Low - High | - |
Turnover | 89.54M |
Profit | -184.16M |
EPS - Basic | -1.7380 |
PE Ratio | -1.73 |
Market Cap | 319.48M |
Achieving success in Australian casinos requires a combination of skill, strategy, and a bit of luck. Understanding the nuances of different casino games and applying effective betting strategies is essential for maximizing wins. From mastering popular table games like poker, blackjack and roulette to cracking slot machine code, players c...
Continue Reading
Both poker and investing require skill, discipline, and a strategic approach to managing resources. While poker might seem worlds apart from the stock market, the principles of bankroll management align closely with sound investment practices. Here’s how these two realms share common ground. Risk Management Poker and investing both ...
Continue Reading
The advent of online casinos has revolutionized the gambling landscape, offering unprecedented convenience and access. Among the latest trends is the emergence of online casinos with no KYC (Know Your Customer) requirements, such as https://www.sportscasting.com/online-casinos/no-kyc/. These platforms allow players to engage in gambl...
Continue Reading
The surge in interest surrounding non-GamStop casinos has undeniably sparked a nuanced discourse around the legal implications involved. As online gambling continues to expand, the presence of non-GamStop sites represents a compelling alternative for those seeking more lenient gaming platforms. These platforms operate independently of the...
Continue Reading
London stocks fell in early trade on Thursday as investors waded through another deluge of corporate news, but Admiral bucked the trend after impressive results. At 0855 GMT, the FTSE 100 was down 0.6% at 8,707.21. Matt Britzman, senior equity analyst at Hargreaves Lansdown, said: “The UK markets have failed to latch ...
Continue Reading
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions